日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort study

尽管ANCA相关性血管炎患者的糖皮质激素暴露量减少，但长期预后仍未改变：多中心REVEAL队列研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1807423
Shiomi, Mayu; Watanabe, Ryu; Hatta, Muneyuki; Matsuda, Shogo; Kotani, Takuya; Okazaki, Ayana; Masuda, Yuichi; Shoji, Mikihito; Manabe, Atsushi; Kadoba, Keiichiro; Yoshida, Tsuneyasu; Ito, Naoko; Fujiki, Youhei; Miyake, Hirofumi; Yamamoto, Wataru; Hashimoto, Motomu
免疫/内分泌
发表日期：2026
文献求助 收藏

Hepatocyte growth factor as a driver of synovial inflammation and therapeutic resistance in rheumatoid arthritis

肝细胞生长因子是类风湿性关节炎滑膜炎症和治疗耐药性的驱动因素

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1718591
Dang, Quang Minh; Watanabe, Ryu; Iwasaki, Takeshi; Ishihara, Ryuhei; Kadoba, Keiichiro; Murata, Koichi; Tanaka, Masao; Ito, Hiromu; Tran, Thanh Duc; Nguyen, Sang Quang Tran; Van Nguyen, Khanh; Sun, Hongxin; Katsushima, Masao; Zhang, Hui; Yamada, Yutaro; Mamoto, Kenji; Okano, Tadashi; Dung, Tran Trung; Thuy, Le Thi Thanh; Hashimoto, Motomu
炎症
细胞生物学
炎症/感染
治疗耐药
滑膜炎
关节炎
发表日期：2026
文献求助 收藏

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects

结缔组织病相关性肺动脉高压：当前治疗策略和未来展望

期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom16010140
Yokoyama, Yukina Mizuno; Watanabe, Ryu; Yamaguchi, Tomohiro; Ishihara, Ryuhei; Shiomi, Mayu; Fujita, Yuya; Katsushima, Masao; Fukumoto, Kazuo; Haji, Yoichiro; Yamada, Shinsuke; Hashimoto, Motomu
肺动脉高压
心血管
发表日期：2026
文献求助 收藏

Correction: Smartphone App-Based Eating Behavior Monitoring and Feedback Intervention for Glucocorticoid-Induced Appetite Increase in Patients With Systemic Lupus Erythematosus: Protocol for a Pilot Randomized Controlled Trial

更正：基于智能手机应用程序的饮食行为监测和反馈干预治疗系统性红斑狼疮患者糖皮质激素诱发的食欲增加：一项试点随机对照试验方案

期刊:JMIR Research Protocols
影响因子:1.5
doi:10.2196/90010
Yamaguchi, Takashi; Takahashi, Nobuyuki; Inanaga, Ryohei; So, Ryuhei; Kikuchi, Hiroe; Noma, Hisashi; Sasai, Hiroyuki; Kamada, Kazuro; Sugimoto, Tomohiro; Tsushima, Hiroshi; Ichikawa, Takanori; Miyake, Hirofumi; Fujita, Shunichi; Ono, Keisuke; Miwa, Yusuke; Hasegawa, Anna; Suzuki, Naoki; Onishi, Akira; Matsui, Toshihiro; Watanabe, Ryu; Hasegawa, Yasuhiro; Ono, Rei; Isozaki, Takeo; Ishikawa, Yuichi; Yajima, Nobuyuki; Kurita, Noriaki
红斑狼疮
免疫/内分泌
发表日期：2026
文献求助 收藏

Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort study

在多中心 REVEAL 队列研究中，利妥昔单抗与静脉注射环磷酰胺治疗重症 ANCA 相关性血管炎的长期疗效比较

期刊:Journal of Internal Medicine
影响因子:9.2
doi:10.1111/joim.70024
Matsuda, Shogo; Kotani, Takuya; Nishioka, Daisuke; Okazaki, Ayana; Masuda, Yuichi; Taniguchi, Tomoki; Shoji, Mikihito; Yoshida, Tsuneyasu; Hiwa, Ryosuke; Shiomi, Mayu; Watanabe, Ryu; Hatta, Muneyuki; Ito, Naoko; Fujiki, Yohei; Miyake, Hirofumi; Yamamoto, Wataru; Hashimoto, Motomu; Takeuchi, Tohru
发表日期：2025
文献求助 收藏

Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies

比较使用美泊利单抗和贝那利珠单抗靶向IL-5的疗效：增强EGPA治疗策略

期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom15040544
Shiomi, Mayu; Watanabe, Ryu; Ishihara, Ryuhei; Tanaka, Sayaka; Nakazawa, Takashi; Hashimoto, Motomu
IL-5
发表日期：2025
文献求助 收藏

The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy

系统性自身免疫性疾病中的I型干扰素轴：从分子通路到靶向治疗

期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom15111586
Ishihara, Ryuhei; Watanabe, Ryu; Shiomi, Mayu; Fujita, Yuya; Katsushima, Masao; Fukumoto, Kazuo; Yamada, Shinsuke; Hashimoto, Motomu
信号转导
自身免疫性疾病
免疫/内分泌
发表日期：2025
文献求助 收藏

Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study

皮下注射沙利珠单抗200 mg每两周一次、皮下注射托珠单抗162 mg每两周一次以及静脉注射托珠单抗8 mg/kg每4周一次在类风湿性关节炎患者中的疗效比较：一项前瞻性队列研究

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-025-03514-x
Onishi, Akira; Tanaka, Masao; Fujii, Takayuki; Murata, Koichi; Murakami, Kosaku; Hashimoto, Motomu; Watanabe, Ryu; Nozaki, Yuji; Ashida, Chisato; Yamamoto, Wataru; Yamada, Hirotaka; Sendo, Sho; Ebina, Kosuke; Makino, Hidehiko; Son, Yonsu; Wada, Yumiko; Hata, Kenichiro; Matsuda, Shuichi; Morinobu, Akio
关节炎
发表日期：2025
文献求助 收藏

Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: a post hoc analysis of the OHZORA trial

奥佐拉利珠单抗在类风湿关节炎患者中显示出疗效，且不受基线类风湿因子 (RF) 和抗环瓜氨酸肽抗体 (ACPA) 滴度的影响：OHZORA 试验的事后分析

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keaf171
Watanabe, Ryu; Tanaka, Yoshiya; Takeuchi, Tsutomu; Okamoto, Shunsuke; Kyuuma, Masanao; Matsumoto, Rumiko; Nakayama, Yoichi; Katsushima, Masao; Hashimoto, Motomu
关节炎
发表日期：2025
文献求助 收藏

Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis

类风湿因子：在类风湿性关节炎中的诊断和预后性能及治疗意义

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14051529
Togashi, Tasuku; Ishihara, Ryuhei; Watanabe, Ryu; Shiomi, Mayu; Yano, Yuya; Fujisawa, Yuhei; Katsushima, Masao; Fukumoto, Kazuo; Yamada, Shinsuke; Hashimoto, Motomu
关节炎
发表日期：2025
文献求助 收藏